BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10926437)

  • 1. Itraconazole in human medicine and veterinary practice.
    Sousa YV; Santiago MG; de Souza BM; Keller KM; Oliveira CSF; Mendoza L; Vilela RVR; Goulart GAC
    J Mycol Med; 2024 Jun; 34(2):101473. PubMed ID: 38493607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing infectious challenges in the age of molecular-targeted therapies for adult hematological malignancies.
    Shah M; El Chaer F; Ho DY; El Boghdadly Z
    Transpl Infect Dis; 2024 Jun; 26(3):e14283. PubMed ID: 38698640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When a fungal infection is worse than a leukemia diagnosis.
    Attard JA; Attard M
    Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14189. PubMed ID: 38010719
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematological malignancies by Park et al.
    Zhang SX; Ardura MI; Park SY
    Clin Microbiol Infect; 2024 May; ():. PubMed ID: 38729305
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.
    Grau S; de la Cámara R; Sabater FJ; Jarque I; Carreras E; Casado MA; Sanz MA
    BMC Infect Dis; 2012 Apr; 12():83. PubMed ID: 22471553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antifungal therapy.
    Johnson MD; MacDougall C; Ostrosky-Zeichner L; Perfect JR; Rex JH
    Antimicrob Agents Chemother; 2004 Mar; 48(3):693-715. PubMed ID: 14982754
    [No Abstract]   [Full Text] [Related]  

  • 7. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC
    Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
    Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
    Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
    Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies.
    Cahuayme-Zuniga L; Lewis RE; Mulanovich VE; Kontoyiannis DP
    Med Mycol; 2012 Jul; 50(5):543-8. PubMed ID: 22103347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis and treatment of fungal infections associated with haematological malignancies.
    Ascioglu S; de Pauw BE; Meis JF
    Int J Antimicrob Agents; 2000 Aug; 15(3):159-68. PubMed ID: 10926437
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.